Andrew Left of Citron Research reignited

the campaign against Palantir Technologies Inc. (NYSE:PLTR), intensifying his argument that the stock is significantly overvalued and should be priced around $40 per share. 1. **Comparison to Databricks**: Citron Research compared Palantir's valuation to that of private competitor Databricks, highlighting Palantir's slower growth on several key metrics. Databricks has been valued at $100 billion in the private markets, leading Citron to argue that if Palantir were given the same valuation, its stock price would be $40, serving as a "flashing warning sign" of its true value. 2. **OpenAI's Valuation Benchmark**: Citron used OpenAI's recent $500 billion valuation as a benchmark, calculating that applying the same 17x price-to-sales multiple to Palantir's projected 2026 revenue of $5.6 billion would imply a stock price of approximately $40 per share. 3. **Market Reaction and Price Target**: Following Citron's reports, Palantir's stock has experienced significant declines, with shares down 16% over the past five trading days. Citron has consistently reiterated its $40 per share price target, implying a potential downside of around 77% from Palantir's current stock price of $173.64. 4. **Influence and Aggression**: Andrew Left's aggressive stance, including doubling down on his short position and price target, has captured attention and weighed on investor sentiment. His use of prominent comparisons like OpenAI's valuation serves to underscore his argument and amplify the pressure on Palantir's stock. In conclusion, Andrew Left's Citron Research has forcefully argued that Palantir's current stock price far exceeds its intrinsic value, using comparisons to Databricks and OpenAI's valuation to support a compelling case for a sharp decline in the stock's price to around $40 per share.